RA & SpA in remission - if you taper biologic or JAK, what happens to infection risk = Nothing! Metanalysis of 13 studies 2260 pts in remission finds no diff in serious infx rate in taper group(1.7/100PY) vs usual care(2.6/100PY)(p=0.13); no diff in SAE! https://t.co/FqXyVOKLs7